Development of Innovative Strategies for Early Detection, Prevention, and Control of Emerging Infectious Diseases in the United States Through Integrated Public Health Systems

Abstract

Background: As strikingly shown by the series of shocks-H1N1 influenza, MERS-CoV,
Ebola, Zika, and most recently the SARS-CoV-2 epidemic, which claimed more than 1.2
million lives in the United States and caused an projected $14 trillion in combined direct and
indirect economic damage-the emergence and re-emergence of new infectious diseases is
an ongoing and increasing danger to U.S. public health security. These repeated cautions
notwithstanding, the United States still lacks a totally integrated, real-time national infectious
disease early warning system able to identify new pathogen signals with the speed and spatial
resolution needed for successful pre-epidemic response. This study offers and assesses an
Integrated Early Warning and Containment System (IEWACS) framework meant to
methodically improve U.S. capability for early identification, prevention, and management of
new infectious diseases by combining digital epidemiology, genomic surveillance, community
health informatics, and cross-sector coordination tools.
A mixed-methods technique using narrative systematic review, expert consensus analysis, and
scenario-based simulation modeling was used. Synthesized were seven federal policy
documents, four overseas epidemic response case studies, and eighty-one peer-reviewed
articles. Using epidemiological data from U.S. epidemic histories (2009-2024), simulation
modeling-minimal, moderate, and full deployment-estimated expected detection
acceleration and containment effectiveness across three IEWACS implementation
circumstances. Stakeholder views were included by means of organized synthesis of openly
accessible expert testimony submitted to HHS, CDC, and Congressional hearings on pandemic
preparedness from 2020-2025.
Outcomes: Compared to baseline systems, full IEWACS installation was expected to cut
mean time from pathogen emergence to confirmed public health warning by 8.3 days (95% CI:
5.1-11.5 days)-a decrease that, applied retroactively to the SARS-CoV-2 emergence timeline,
would have allowed significant containment intervention roughly two incubation cycles ahead

of the first confirmed U.S. case cluster. Integrating genomic surveillance was found to be the
single best-yielding component for detection improvement, lowering the expected 3.2 days
from a historical average of 16 days. Integrated with wastewater epidemiology and emergency
department chief complaint data, community-based digital symptom surveillance added a
4.1-day detecting edge over clinical laboratory-dependent methods only.
Finally,: Next-generation U.S. infectious disease early warning is well-founded and
operationally actionable thanks to the IEWACS framework. Its implementation calls for
legislative funding in CDC Core Capabilities, growth of the National Wastewater Surveillance
System, speed-up of whole-genome sequencing integration across public health labs, and
creation of a National Digital Epidemiology Center with real-time data aggregation power. The
next pandemic's human and financial cost of delayed diagnosis will exceed the expense of
developing the infrastructure that could stop it.